Development of High-content Assays for Compound Screening and Hit Validation



June 10, 2014

Phenotypic screening has highly emerged in the past years. Especially High-Content Screening (HCS) has gained strong acceptance in the field of target validation and compounds screening as a method to follow more innovative and sophisticated assays. In line with this, the academic environment has the great power to provide a rich set of novel biological targets that now can be addressed with high-content imaging. We have established the infrastructure to analyze HCS assays in a sterile environment over several days. This process can be done for bigger compound screening campaigns as our liquid handling system integrates a HCS device. We are running HCS projects in different target areas with various given complexities. However, we are now focusing on running stem cell- and microtissue-based assays for compound screening activities. In particular, we use stem cell assays to analyze the influence of small molecules on differentiation and pluripotency.

Drug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.